NCT06084858View on ClinicalTrials.gov

Effect of Changes in Dialysate Bicarbonate on Serum Calcification Propensity and Calciprotein Particles in Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

August 1, 2024

Conditions
End Stage Renal Disease
Interventions
OTHER

Dialysate bicarbonate modification

Dialysate bicarbonate prescription will be modified from low (27 mmol/l) to high (37 mmol/l) in a step-wise fashion

Trial Locations (1)

4020

Ordensklinikum Linz GmbH Elisabethinen, Linz

All Listed Sponsors
lead

Prim. Priv. Doz. Dr. Daniel Cejka

OTHER

NCT06084858 - Effect of Changes in Dialysate Bicarbonate on Serum Calcification Propensity and Calciprotein Particles in Hemodialysis Patients | Biotech Hunter | Biotech Hunter